rs77964815

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000091.5(COL4A3):​c.4484A>G​(p.Gln1495Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00915 in 1,614,128 control chromosomes in the GnomAD database, including 82 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0056 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0095 ( 79 hom. )

Consequence

COL4A3
NM_000091.5 missense

Scores

3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 2.14

Publications

15 publications found
Variant links:
Genes affected
COL4A3 (HGNC:2204): (collagen type IV alpha 3 chain) Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010]
MFF-DT (HGNC:41067): (MFF divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00907886).
BP6
Variant 2-227308920-A-G is Benign according to our data. Variant chr2-227308920-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 254998.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00564 (859/152386) while in subpopulation NFE AF = 0.0103 (700/68046). AF 95% confidence interval is 0.00966. There are 3 homozygotes in GnomAd4. There are 346 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000091.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A3
NM_000091.5
MANE Select
c.4484A>Gp.Gln1495Arg
missense
Exon 49 of 52NP_000082.2Q01955-1
MFF-DT
NR_102371.1
n.48-3265T>C
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A3
ENST00000396578.8
TSL:1 MANE Select
c.4484A>Gp.Gln1495Arg
missense
Exon 49 of 52ENSP00000379823.3Q01955-1
MFF-DT
ENST00000439598.6
TSL:1
n.48-3265T>C
intron
N/A
COL4A3
ENST00000469504.2
TSL:1
n.434-284A>G
intron
N/AENSP00000493493.1A0A2R8Y2F0

Frequencies

GnomAD3 genomes
AF:
0.00563
AC:
858
AN:
152268
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00166
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.00222
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00455
Gnomad FIN
AF:
0.00169
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0103
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00629
AC:
1569
AN:
249324
AF XY:
0.00664
show subpopulations
Gnomad AFR exome
AF:
0.00174
Gnomad AMR exome
AF:
0.00168
Gnomad ASJ exome
AF:
0.00119
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00205
Gnomad NFE exome
AF:
0.0111
Gnomad OTH exome
AF:
0.00479
GnomAD4 exome
AF:
0.00952
AC:
13913
AN:
1461742
Hom.:
79
Cov.:
32
AF XY:
0.00926
AC XY:
6736
AN XY:
727174
show subpopulations
African (AFR)
AF:
0.00176
AC:
59
AN:
33476
American (AMR)
AF:
0.00192
AC:
86
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000574
AC:
15
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00531
AC:
458
AN:
86256
European-Finnish (FIN)
AF:
0.00289
AC:
154
AN:
53314
Middle Eastern (MID)
AF:
0.00816
AC:
47
AN:
5762
European-Non Finnish (NFE)
AF:
0.0114
AC:
12707
AN:
1111984
Other (OTH)
AF:
0.00641
AC:
387
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
720
1440
2159
2879
3599
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
480
960
1440
1920
2400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00564
AC:
859
AN:
152386
Hom.:
3
Cov.:
33
AF XY:
0.00464
AC XY:
346
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.00166
AC:
69
AN:
41594
American (AMR)
AF:
0.00222
AC:
34
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00476
AC:
23
AN:
4832
European-Finnish (FIN)
AF:
0.00169
AC:
18
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0103
AC:
700
AN:
68046
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
47
94
141
188
235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00852
Hom.:
12
Bravo
AF:
0.00562
TwinsUK
AF:
0.00917
AC:
34
ALSPAC
AF:
0.0125
AC:
48
ESP6500AA
AF:
0.00235
AC:
9
ESP6500EA
AF:
0.00956
AC:
79
ExAC
AF:
0.00676
AC:
817
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00971
EpiControl
AF:
0.00925

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not provided (7)
-
-
6
not specified (6)
-
-
1
Alport syndrome (1)
-
-
1
Benign familial hematuria;C4746745:Autosomal recessive Alport syndrome;C5882663:Autosomal dominant Alport syndrome (1)
-
-
1
Kidney disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
21
DANN
Benign
0.79
DEOGEN2
Benign
0.19
T
Eigen
Benign
-0.099
Eigen_PC
Benign
0.069
FATHMM_MKL
Benign
0.72
D
LIST_S2
Benign
0.84
T
MetaRNN
Benign
0.0091
T
MetaSVM
Uncertain
-0.020
T
MutationAssessor
Benign
0.95
L
PhyloP100
2.1
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
0.49
N
REVEL
Uncertain
0.31
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.66
P
Vest4
0.26
MVP
0.80
MPC
0.20
ClinPred
0.049
T
GERP RS
6.0
Varity_R
0.23
gMVP
0.63
Mutation Taster
=53/47
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77964815; hg19: chr2-228173636; COSMIC: COSV99067741; COSMIC: COSV99067741; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.